Literature DB >> 20665518

IgM MGUS anti-MAG neuropathy with predominant muscle weakness and extensive muscle atrophy.

Yuichi Kawagashira1, Naohide Kondo, Naoki Atsuta, Masahiro Iijima, Haruki Koike, Masahisa Katsuno, Fumiaki Tanaka, Susumu Kusunoki, Gen Sobue.   

Abstract

We report a patient with anti-myelin-associated glycoprotein (MAG) neuropathy, predominantly exhibiting severe motor symptoms, accompanied by extensive muscle atrophy mimicking Charcot-Marie-Tooth disease. Nerve conduction studies revealed mild retardation of motor conduction velocities and significant prolongation of distal latency. Sural nerve biopsy revealed widely spaced myelin and positive staining of myelinated fibers with an IgM antibody. Predominant motor symptoms with muscle atrophy can be one of the clinical manifestations of anti-MAG neuropathy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20665518     DOI: 10.1002/mus.21741

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  5 in total

Review 1.  Diagnosis and treatment of chronic acquired demyelinating polyneuropathies.

Authors:  Norman Latov
Journal:  Nat Rev Neurol       Date:  2014-07-01       Impact factor: 42.937

2.  Distinct lymphocytes subsets in IgM-related neuropathy: clinical-immunological correlations.

Authors:  Raffaele Iorio; Mario Sabatelli; Alessandra Del Grande; Giulia Bisogni; Valentina Damato; Domenico Plantone; Alessandro Marti; Giovanni Frisullo; Angela Romano; Paolo Maria Rossini; Marco Luigetti
Journal:  Neurol Sci       Date:  2014-09-06       Impact factor: 3.307

3.  Anti-MAG IgM: differences in antibody tests and correlation with clinical findings.

Authors:  Sabrina Matà; Stefano Ambrosini; Domenica Saccomanno; Tiziana Biagioli; Marinella Carpo; Aldo Amantini; Fabio Giannini; Alessandro Barilaro; Lucia Toscani; Monica Del Mastio; Giacomo Pietro Comi; Sandro Sorbi
Journal:  Neurol Sci       Date:  2019-10-25       Impact factor: 3.307

4.  Heterogeneity of Polyneuropathy Associated with Anti-MAG Antibodies.

Authors:  Laurent Magy; Raphaël Kaboré; Stéphane Mathis; Prisca Lebeau; Karima Ghorab; Christiane Caudie; Jean-Michel Vallat
Journal:  J Immunol Res       Date:  2015-05-06       Impact factor: 4.818

5.  Functioning and quality of life in patients with neuropathy associated with anti-MAG antibodies.

Authors:  Yuri M Falzone; Marta Campagnolo; Mariangela Bianco; Patrizia Dacci; Daniele Martinelli; Marta Ruiz; Silvia Bocci; Federica Cerri; Angelo Quattrini; Giancarlo Comi; Luana Benedetti; Fabio Giannini; Giuseppe Lauria; Eduardo Nobile-Orazio; Chiara Briani; Raffaella Fazio; Nilo Riva
Journal:  J Neurol       Date:  2018-10-10       Impact factor: 4.849

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.